Chat with us
Research Assistance
Online
  • Please enter your first name.

South Africa Women'S Health Market Size & Outlook, 2026-2033

The women's health market in South Africa is expected to reach a projected revenue of US$ 372.1 million by 2033. A compound annual growth rate of 4.8% is expected of South Africa women's health market from 2026 to 2033.
Revenue, 2025 (US$M)
$248.0
Estimate, 2026 (US$M)
$267.6
Forecast, 2033 (US$M)
$372.1
CAGR, 2026 - 2033
4.8%

South Africa women's health market highlights

  • The South Africa women's health market generated a revenue of USD 248.0 million in 2025 and is expected to reach USD 372.1 million by 2033.
  • The South Africa market is expected to grow at a CAGR of 4.8% from 2026 to 2033.
  • In terms of segment, contraceptives was the largest revenue generating application in 2025.
  • Menopause is the most lucrative application segment registering the fastest growth during the forecast period.


Women's health market data book summary

Market revenue in 2025USD 248.0 million
Market revenue in 2033USD 372.1 million
Growth rate4.8% (CAGR from 2026 to 2033)
Largest segmentContraceptives
Fastest growing segmentMenopause
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationHormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, Polycystic Ovary Syndrome (PCOS)
Key market players worldwideAbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring


Other key industry trends

  • In terms of revenue, South Africa accounted for 0.5% of the global women's health market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, Saudi Arabia women's health market is projected to lead the regional market in terms of revenue in 2033.
  • South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 372.1 million by 2033.

In Africa, approximately 22.6% of women of reproductive age do not have access to advanced contraceptives. Hence, women's health products have not yet penetrated South Africa, but the market is expected to grow at a substantial rate over the forecast period.

Some of the key factors anticipated to result in market growth are high unmet medical needs, increasing awareness about women's health issues, and the growing population of elderly women. Anemia affects approximately one-third of women in South Africa.

Such a high prevalence of anemia is increasing the risk of developing severe women’s health issues in the country. Moreover, according to the International Osteoporosis Foundation, about 1.4 million women aged above 50 are suffering from osteoporosis.

No credit card required*

Publish Date: Feb 11, 2026

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Three ways to get this data

Subscribe to the databook, customize it, or ask a question.

Horizon Databook

Unlock every chart on this page and get dashboard access

  • Statistics1.2M+ across all markets
  • Databooks30K+ global, 120K+ country
  • Companies200K+ profiles
  • ExportPDF, Dashboard, XLS & PNG, licensed to cite

Ask Prism AI

A cited answer in seconds

  • Corpus30,000 studies, 1.2M points
  • ScopeAll markets, not just this
  • CitationTraced to report & table
  • HonestySays "not covered" if so
  • SpeedSeconds, not days
ISO 9001 & 27001 certifiedESOMAR memberNot sure which fits? Call +1-415-854-0727

Women's Health Market Companies

NameProfile# EmployeesHQWebsite
Teva Pharmaceutical Industries LtdView profile 37,851124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020www.tevapharm.com
Amgen IncView profile 26,700One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799www.amgen.com
AbbVie IncView profile 50,0001 North Waukegan Road, North Chicago, IL, United States, 60064-6400www.abbvieinvestor.com
Pfizer IncView profile 88,00066 Hudson Boulevard East, New York, NY, United States, 10001-2192www.pfizer.com
Merck & Co IncView profile 72,000126 East Lincoln Avenue, Rahway, NJ, United States, 07065www.merck.com
Bayer AGView profile 99,723Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368www.bayer.com
FerringView profile 5001-10000Saint-prex, Vaud, Switzerland, Europewww.ferring.com
Agile Therapeutics IncView profile 19500 College Road East, Suite 310, Princeton, NJ, United States, 08540www.agiletherapeutics.com
Blairex LaboratoriesView profile 101-250Columbus, Indiana, United States, North Americawww.blairex.com
ApothecusView profile 11-50Hicksville, New York, United States, North Americaapothecus.com

South Africa Women's Health Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Women's Health Market Outlook will help companies and investors design strategic landscapes.


Contraceptives was the largest segment with a revenue share of 29.96% in 2025.

Horizon Databook has segmented the South Africa women's health market based on hormonal infertility, contraceptives, postmenopausal osteoporosis, endometriosis & uterine fibroids, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2021 to 2033.




In Africa, approximately 22.6% of women of reproductive age do not have access to advanced contraceptives. Hence, women's health products have not yet penetrated South Africa, but the market is expected to grow at a substantial rate over the forecast period.

Some of the key factors anticipated to result in market growth are high unmet medical needs, increasing awareness about women's health issues, and the growing population of elderly women. Anemia affects approximately one-third of women in South Africa.

Such a high prevalence of anemia is increasing the risk of developing severe women’s health issues in the country. Moreover, according to the International Osteoporosis Foundation, about 1.4 million women aged above 50 are suffering from osteoporosis.

  • South Africa Women'S Health Market Application Outlook (Revenue, USD Million , 2021-2033)
    • Hormonal Infertility
    • Contraceptives
    • Postmenopausal Osteoporosis
    • Endometriosis & Uterine Fibroids
    • Menopause
    • Polycystic Ovary Syndrome (PCOS)
  • South Africa Women'S Health Market Drug Class Outlook (Revenue, USD Million , 2021-2033)
    • Hormonal Therapies
    • Bone Health Agents
    • Fertility Agents
    • GnRH Modulators
    • Pain and Symptom Management
    • Metabolic Agents
    • Others Drug Class
  • South Africa Women'S Health Market Age Outlook (Revenue, USD Million , 2021-2033)
    • 50 years and above
    • Others Age

Reasons to subscribe to Women's Health Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Women's Health Market Outlook databook

  • Our clientele includes a mix of Women's Health Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Africa Women's Health Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Africa Women's Health Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

South Africa Women'S Health Market, 2021-2033 (US$M)

No Access Stack Chart

South Africa women's health market statistics, by application, 2021-2033 (US$M)

No Access Pie Chart

South Africa women's health market statistics, by application, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more